Ron Brill
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Ron Brill
News from Ron Brill
